Epigenetic modifications in colorectal cancer: Molecular insights and therapeutic challenges

被引:92
|
作者
Vaiopoulos, Aristeidis G. [1 ]
Athanasoula, Kalliopi Ch. [1 ]
Papavassiliou, Athanasios G. [1 ]
机构
[1] Univ Athens, Dept Biol Chem, Sch Med, Athens 11527, Greece
关键词
Colorectal cancer; Epigenetics; Histone modification; DNA methylation; Therapy; Prognosis; GLOBAL HISTONE MODIFICATION; TUMOR-SUPPRESSOR GENES; COLON-CANCER; PHASE-I; DNA METHYLATION; DOWN-REGULATION; BETA-CATENIN; E-CADHERIN; COMBINATION; CELLS;
D O I
10.1016/j.bbadis.2014.02.006
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Colorectal cancer, a leading cause of mortality worldwide, is a multistep disorder that results from the alteration of genetic and epigenetic mechanisms under contextual influence. Epigenetic aberrations, including DNA methylation, histone modifications, chromatin remodeling and non-coding RNAs, affect every aspect of tumor development from initiation to metastasis. Cancer stem cell promotion is also included in the wide spectrum of epigenetic dysregulations. Elucidation of this complex crosstalk network may offer new insights in the molecular interactions involved in the pathogenesis of colorectal carcinogenesis. In the era of translational medicine new horizons are opened for the pursuit of personalized therapeutic approaches and the development of novel and accurate diagnostic, prognostic and therapy-assessment markers. This review discusses the implications of epigenetic mechanisms in tumor biology and their applications "from bench to bedside". (C) 2014 Elsevier B.V. All rights reserved.
引用
收藏
页码:971 / 980
页数:10
相关论文
共 50 条
  • [1] Drugs Targeting Epigenetic Modifications and Plausible Therapeutic Strategies Against Colorectal Cancer
    Patnaik, Srinivas
    Anupriya
    FRONTIERS IN PHARMACOLOGY, 2019, 10
  • [2] Epigenetic Modifications: Therapeutic Potential in Cancer
    Sachan, Manisha
    Kaur, Manpreet
    BRAZILIAN ARCHIVES OF BIOLOGY AND TECHNOLOGY, 2015, 58 (04) : 526 - 539
  • [3] The role of epigenetic modifications in Colorectal Cancer Metastasis
    Riya Su
    Xinlin Wu
    Liang Tao
    Changshan Wang
    Clinical & Experimental Metastasis, 2022, 39 : 521 - 539
  • [4] The role of epigenetic modifications in Colorectal Cancer Metastasis
    Su, Riya
    Wu, Xinlin
    Tao, Liang
    Wang, Changshan
    CLINICAL & EXPERIMENTAL METASTASIS, 2022, 39 (04) : 521 - 539
  • [5] Somatic mutations in colorectal cancer are associated with the epigenetic modifications
    Lei, Hongwei
    Tao, Kaixiong
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2020, 24 (20) : 11828 - 11836
  • [6] Epigenetic Modifications: Novel Therapeutic Approach for Thyroid Cancer
    Zhu, Xuguang
    Cheng, Sheue-yann
    ENDOCRINOLOGY AND METABOLISM, 2017, 32 (03) : 326 - 331
  • [7] Colorectal cancer screening—insights and challenges
    Stephen P. Halloran
    Nature Reviews Gastroenterology & Hepatology, 2014, 11 : 586 - 587
  • [8] Epigenetic Modifications as Therapeutic Targets
    Zheng, Yi-Chao
    Feng, Si-Qi
    CURRENT DRUG TARGETS, 2020, 21 (11) : 1046 - 1046
  • [9] Epigenetic modifications as therapeutic targets
    Theresa K Kelly
    Daniel D De Carvalho
    Peter A Jones
    Nature Biotechnology, 2010, 28 : 1069 - 1078
  • [10] Epigenetic modifications as therapeutic targets
    Kelly, Theresa K.
    De Carvalho, Daniel D.
    Jones, Peter A.
    NATURE BIOTECHNOLOGY, 2010, 28 (10) : 1069 - 1078